30
CARDIOVASCULAR
hamburger


 
 
 

Powerfully Connected

Abbott's ICD and CRT-D solutions offer built-in smartphone connectivity — to help transform how you and patients connect.

The secure myMerlinPulse™ app streamlines remote monitoring to encourage continuous, reliable patient engagement so that you may have earlier detection of clinically relevant events.

Pioneering Dynamic Technology

Abbott’s next generation ICD and CRT-D solutions combine smartphone-enabled remote monitoring with patient-focused enhancements to help you deliver accurate, optimized care.

  • POWERFUL, LONG-LASTING THERAPY
    in a small, contoured shape with 1.5T and 3T MRI compatibility
  • ENHANCED DETECTION AND TREATMENT
    of challenging ventricular arrhythmias with Abbott's unique discriminator — VF Therapy Assurance¹
  • ADVANCED CRT TECHNOLOGY
    with faster, more intuitive programming options
Gallant DR and HF devices

Patient-Centric Outcomes

Abbott’s ICD and CRT-D solutions are designed to seamlessly integrate into your patients' day-to-day lives, making it possible for you to achieve clinically meaningful outcomes.
 

98.4% of patients
did not receive inappropriate shocks at 1 year (CI: 97.2-99.2, p<0.0001).²

22% fewer hospitalizations
for patients with SyncAV™ CRT technology enabled versus patients with the technology disabled.³

Next Generation ICD and CRT-D Solutions

Resource Library

Customer Brochure - Gallant and Entrant Devices Overview

Learn about Abbott’s next generation ICD and CRT-D solutions with built-in smartphone connectivity and patient-focused enhancements that help to ensure accurate, optimized care.

Remote Monitoring Clinician Guide

Get guidance and recommendations for how to onboard patients using myMerlinPulse™ app for remote monitoring.

Smartphone Connectivity Guide

Learn how built-in smartphone connectivity helps to streamline remote monitoring and encourage continuous, reliable patient engagement.

Empowering You. Empowering Your Patients. Powered By Abbott.

These devices are commercially available for use in select international markets.

References

  1. Data on file. 60101422 Internal Validation Report. Total 2019 global high-voltage implants, all manufacturers, estimated to be 440,434 units (Source: Abbott Market Research).
  2. Veltmann C, Wöhrle, Busch M, et al. Reduction of inappropriate shocks of ICDs with enhanced SVT discriminators. EUROPACE presentation; 2017.
  3. Varma N, O’Donnell D, Bassiouny M, et al. Programming cardiac resynchronization therapy for electrical synchrony: reaching beyond left bundle branch block and left ventricular activation delay. J Am Heart Assoc. 2018;7:e007489.

Brief Summary: This product is intended for use by or under the direction of a Physician. Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

MAT-2009257 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

True
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.